Dimerix Ltd. | Income Statement

Fiscal year is July-June. All values AUD Thousands.
2013
2014
2015
2016
2017
Cost of Goods Sold (COGS) incl. D&A
-
-
1.00
1.90
1.50
Gross Income
-
-
1.00
1.90
1.50
SG&A Expense
461.00
590.20
678.30
1,888.00
2,311.60
EBIT
-
590.20
679.30
1,889.90
2,313.20
Unusual Expense
188.50
-
100.00
3,971.80
-
Non Operating Income/Expense
34.80
21.60
68.30
1.10
-
Pretax Income
517.10
528.00
679.50
5,817.40
2,294.90
Income Tax
-
-
-
563.00
536.30
Consolidated Net Income
517.10
528.00
679.50
5,254.50
1,758.50
Net Income
517.10
528.00
679.50
5,254.50
1,758.50
Net Income After Extraordinaries
517.10
528.00
679.50
5,254.50
1,758.50
Net Income Available to Common
517.10
528.00
679.50
5,254.50
1,758.50
EPS (Basic)
0.04
0.03
0.03
0.07
0.02
Basic Shares Outstanding
13,294.40
17,384.90
20,908.10
71,398.10
85,241.30
EPS (Diluted)
0.04
0.03
0.03
0.07
0.02
Diluted Shares Outstanding
13,294.40
17,384.90
20,908.10
71,398.10
85,241.30
EBITDA
461.00
590.20
678.30
1,888.00
2,311.60
Non-Operating Interest Income
97.60
40.60
31.40
45.30
18.30

About Dimerix

View Profile
Address
Level 11
Melbourne Victoria (VIC) 3000
Australia
Employees -
Website http://www.dimerix.com
Updated 07/08/2019
Operates as a biotechnology company .